406 Aflibercept (Zaltrap) directly attenuates the migration and invasion of colorectal cancer cells
Bouygues, A, Mésange, P, Ayadi, M, Poindessous, V, Chiron, M, Dochy, E, André, T, de Gramont, A, Larsen, A.K
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
PD-010 Erlotinib attenuates bevacizumab-mediated activation of EGFR-survival signaling in CRC models independent of KRAS status providing a rational basis for the DREAM phase III clinical trial
Mésange, P., Bouygues, A., Muller, D., Savina, A., Chibaudel, B., Tournigand, C., André, T., de Gramont, A., Larsen, A.
Published in Annals of oncology (01.06.2015)
Published in Annals of oncology (01.06.2015)
Get full text
Journal Article
A66 PH: MOLECULES, CELLS AND ANIMAL MODELS: Bmpr2 Deficiency Potentiates The Ltb4 Mediated Paec Transformation In Pah
Tian, W, Jiang, X, Qian, J, Tu, A, Shuffle, E, Mesange, P, Nicolls, M
Published in American journal of respiratory and critical care medicine (01.01.2016)
Get full text
Published in American journal of respiratory and critical care medicine (01.01.2016)
Journal Article
Natural Bevacizumab Resistance is Associated with Hypoxia Tolerance and Prolonged Activation of Autocrine Vegf Signaling in Colorectal Cancer Cells and Can Be Overcome By Nintedanib, a Triple Angiokinase Inhibitor
Mesange, P., Poindessous, V., Sabbah, M., Escargueil, A.E., De Gramont, A., Larsen, A.K.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
1582PNATURAL BEVACIZUMAB RESISTANCE IS ASSOCIATED WITH HYPOXIA TOLERANCE AND PROLONGED ACTIVATION OF AUTOCRINE VEGF SIGNALING IN COLORECTAL CANCER CELLS AND CAN BE OVERCOME BY NINTEDANIB, A TRIPLE ANGIOKINASE INHIBITOR
Mesange, P., Poindessous, V., Sabbah, M., Escargueil, A.E., De Gramont, A., Larsen, A.K.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
P-221 Acquired 5-FU resistance in CRC models is accompanied by upregulation of VEGF-VEGFR1 signaling, increased migration and invasion that can be attenuated by aflibercept
Bouygues, A., Mesange, P., Ayadi, M., Chiron, M., Dochy, E., Andre, T., de Gramont, A., Larsen, A.
Published in Annals of oncology (01.06.2015)
Published in Annals of oncology (01.06.2015)
Get full text
Journal Article
1581PMOUSE-DREAM: VEGF INHIBITION IS ACCOMPANIED BY EGFR ACTIVATION IN COLORECTAL CANCER MODELS INDEPENDENT OF KRAS STATUS PROVIDING A RATIONAL FOR COMBINATIONS OF BEVACIZUMAB AND ERLOTINIB IN THE POSITIVE GERCOR PHASE III DREAM TRIAL
Larsen, A.K., Poindessous, V., Bouygues, A., Muller, D., Savina, A., Chibaudel, B., Tournigand, C., André, T., De Gramont, A., Mesange, P.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Mouse-Dream: Vegf Inhibition is Accompanied By Egfr Activation in Colorectal Cancer Models Independent of Kras Status Providing a Rational for Combinations of Bevacizumab and Erlotinib in the Positive Gercor Phase III Dream Trial
Larsen, A.K., Poindessous, V., Bouygues, A., Muller, D., Savina, A., Chibaudel, B., Tournigand, C., André, T., De Gramont, A., Mesange, P.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
497OBEVACIZUMAB-ERLOTINIB AS MAINTENANCE THERAPY IN METASTATIC COLORECTAL CANCER. FINAL RESULTS OF THE GERCOR DREAM STUDY
Chibaudel, B., Tournigand, C., Samson, B., Scheithauer, W., Mesange, P., Lledo, G., Viret, F., Ramée, J.F., Tubiana-Mathieu, N., Dauba, J., Dupuis, O., Rinaldi, Y., Mabro, M., Aucoin, N., Latreille, J., Bonnetain, F., Louvet, C., Larsen, A.K., André, T., De Gramont, A.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Bevacizumab-Erlotinib As Maintenance Therapy in Metastatic Colorectal Cancer. Final Results of the Gercor Dream Study
Chibaudel, B., Tournigand, C., Samson, B., Scheithauer, W., Mesange, P., Lledo, G., Viret, F., Ramée, J.F., Tubiana-Mathieu, N., Dauba, J., Dupuis, O., Rinaldi, Y., Mabro, M., Aucoin, N., Latreille, J., Bonnetain, F., Louvet, C., Larsen, A.K., André, T., De Gramont, A.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article